Generic Drug Interchangeability

Generic Drug Interchangeability is a pharmacoeconomic and regulatory construct that denotes the scientific and clinical determination that a generic drug product can be substituted for a brand-name drug product without significant difference in safety, efficacy, or intended effect under the conditions of intended use, thereby enabling therapeutic equivalence within health system frameworks.

43

Publications

1.1K

Citations

131

Authors

68

Institutions

Publications per year

2017–2026

8

Authors

131

  1. SC
    Shein‐Chung Chow

    Duke University, United States

    3 publications · 80 citations

    3

    h-index

  2. JP
    Jennifer Pereira

    University of Toronto, Canada

    3 publications · 75 citations

    3

    h-index

  3. CH
    Charles H. Goldsmith

    McMaster University, Canada

    2 publications · 65 citations

    2

    h-index

  4. LE
    László Endrényi

    University of Toronto, Canada

    2 publications · 55 citations

    2

    h-index

  5. AH
    Anne Holbrook

    McMaster University, Canada

    2 publications · 65 citations

    2

    h-index

1–5 of 131

Venues

  1. PubMed

    Repository · 7 publications · 224 citations

    7

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 4 publications · 94 citations

    4

    h-index

  3. The Journal of Clinical Psychiatry

    2 publications · 48 citations

    2

    h-index

  4. Journal of Bioequivalence & Bioavailability

    2 publications · 36 citations

    2

    h-index

  5. Journal of Biopharmaceutical Statistics

    JBS · 2 publications · 47 citations

    2

    h-index

1–5